EU Probes Cephalon, Teva Deal Over Generic Provigil
By Mandi Woodruff ( April 28, 2011, 6:56 PM EDT) -- The European Union's antitrust watchdog said Thursday it had launched a formal probe of U.S. pharmaceutical giant Cephalon Inc.'s alleged attempt to pay Teva Pharmaceutical Industries Ltd. to keep a generic version of narcolepsy drug Provigil off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.